The Inevitability and Ethics of Inaccurate Screening in Clinical Trials: A Call for Research and Guidance
Author:
Open Access
- 1 July 2021
- journal article
- research article
- Published by Wiley in Ethics & Human Research
- Vol. 43 (4) , 37-44
Abstract
Accurate screening of potential research participants is vital to ensuring the scientific, regulatory, and ethical appropriateness of clinical trials. Yet there are no definitive screening tests for many conditions, and many screening tests, even when implemented correctly, yield some inaccurate results. Sponsors, researchers, and review committees thus routinely face the question of when it is acceptable to approve and conduct clinical trials that rely on screening measures that are known to exclude some eligible individuals and to include some ineligible ones. This article calls attention to and proposes preliminary guidance to address this important issue.Keywords
This publication has 4 references indexed in Scilit:
- Chlorhexidine versus routine bathing to prevent multidrug-resistant organisms and all-cause bloodstream infections in general medical and surgical units (ABATE Infection trial): a cluster-randomised trialThe Lancet, 2019
- Concealment and fabrication: The hidden price of payment for research participation?Clinical Trials, 2013
- Stress Testing and Non-Invasive Coronary Angiography in Patients with Suspected Coronary Artery Disease: Time for a New ParadigmHeart International, 2012
- What Makes Clinical Research Ethical?JAMA, 2000